European Archives - Page 1045 of 1369 - European Medical Journal

Advancements and Challenges in IVF on the 40th Birthday of Louise Brown

On this day, 40 years ago, the first baby was born after conception by in vitro fertilisation (IVF), a momentous occasion in the history of healthcare.

Strengthening the Brain’s Reward Circuit Could Help Treat Autism

Children with autism have impairments in a brain circuit that normally makes social interactions feel rewarding, thereby inhibiting the development…

Positive News from 2017 Mortality Data

Mortality data in England and Wales for 2017 has displayed a reduction in age-standardised death rates compared with the previous year. The new release…

Kite and Gadeta Announce Strategic Collaboration to Advance Gamma Delta T Cell Receptor Technology for Solid Tumors

Kite, a Gilead Company (Nasdaq: GILD), and Gadeta B.V., a privately-held company focused on the discovery and development of novel cancer immunotherapies…

New Target for Drug Development in TB Identified

Tuberculosis (TB) treatments could be developed following results of a study that has identified a potential new drug target for the condition. A team…

Improving Sleep Could Reduce the Risk of Dementia

Dementia onset is significantly more likely if a person experiences sleep disturbances during midlife or late life, according to a new study from the…

Exercise and Physiotherapy in the Management of Parkinson’s: An Interview with Dr Katherine Baker

During a captivating 2 days at European Neuro Convention, an event which took place at the ExCel London from 6th–7th June 2018…

The European Medical Journal Presents: EMJ Allergy & Immunology 3.1

The European Medical Journal has published the latest edition of the EMJ Allergy & Immunology eJournal, which includes a comprehensive review of this…

Multiplex Component-Based Allergy Diagnostics

In vitro assays for specific IgE based on purified allergen components (defined partial allergen diagnostics, DPA-Dx) provide in-depth characterisation…

Take a Breath of Real-World Evidence

Allergen immunotherapy (AIT) in the form of subcutaneous or sublingual immunotherapy (SCIT/SLIT) is the only treatment for allergic rhinitis (AR) and/or…